NHLBI Research Initiatives

From time to time, the NHLBI invites investigators to submit grant applications or contract proposals for specific research programs. We are currently soliciting applications for the programs described below. Please visit the URL listed with each program to obtain information about important application dates and deadlines. For full details of these and other research initiatives, visit www.nhlbi.nih.gov/funding/inits/index.htm.

Animal Stem Cell Research: Novel Approaches to Enhance

• Initiative Number: PA-07-303/304
• Objective: Enhance animal stem cells as model biological systems for the study of biological and disease processes, for the development of therapeutics, and for the development of replacement tissues, through understanding of control of cellular differentiation.

Ataxia-Telangiectasia: Understanding and Treating

• Initiative Number: PA-07-272/273
• Objective: Conduct basic and translational studies to determine how symptoms of ataxia-telangiectasia (AT) develop, to stimulate the development of resources to further AT research, to accelerate research into promising therapeutic approaches for AT, and to stimulate progress in AT research through encouraging and facilitating interdisciplinary interactions.

Bioengineering and Obesity

• Initiative Number: PA-07-354
• Objective: Develop and validate new and innovative engineering approaches to address clinical problems related to energy balance, intake, and expenditure. This PA using the R01 funding mechanism runs in parallel with an RFA of identical scientific scope using the R21 funding mechanism.

Bioengineering Research Partnerships

• Initiative Number: PAR-07-352
• Objective: Apply integrated, multidisciplinary, systems approaches to significant areas of basic bioengineering research and encourage collaborations and partnerships among the allied quantitative and biomedical disciplines.

Children and Adolescents: Chronic Illness Self-Management

• Initiative Number: PA-07-097/098/099
• Objective: Improve self-management and quality of life in children and adolescents ages 8 to 21 with chronic illnesses. Biobehavioral studies of children in the context of family and family-community dynamics are encouraged.

Critical Care: Multidisciplinary Translational Research

• Initiative Number: PA-07-233
• Objective: Conduct interdisciplinary translational research on the care of high-risk, critically ill patients in intensive care units.

Diet Composition and Energy Balance

• Initiative Number: PA-07-218
• Objective: Investigate the role of diet composition in energy balance, in both animals and humans. Collaborations between basic and clinical researchers are particularly encouraged.

Heart Failure: Improving Disease Management

• Initiative Number: PA-07-355
• Objective: Identify and disseminate clinically effective disease management tools into clinical practice to reduce heart failure morbidity and mortality and improve patient outcomes.

Hyperglycemic Exacerbation of Ischemia/Reperfusion Injury after Ischemic Insult

• Initiative Number: PA-07-323
• Objective: Clarify the mechanisms whereby elevated blood glucose increases myocardial ischemia and reperfusion injury following an acute ischemic insult.

Hypersensitivity Pneumonitis: Early Identification and Mechanisms of Disease

• Initiative Number: PA-07-300
• Objective: Investigate basic mechanisms and early clinical identification of hypersensitivity pneumonitis interstitial lung disease in order to elucidate how chronic disease progresses and how it can evolve into either interstitial fibrosis or airway obstructive disease (emphysema).

Metabolomics: Application for Translational and Biological Research

• Initiative Number: PA-07-301/302
• Objective: Apply metabolomic technologies for translational research in human health and disease to enable and improve disease detection, diagnosis, risk assessment, prognosis, and prediction of therapeutic responses.

Nanoscience and Nanotechnology in Biology and Medicine

• Initiative Number: PAR-07-270/271
• Objective: Carry out biological and medical research and development on the understanding and control of matter at the atomic, molecular, or macromolecular levels, at a length scale of approximately 1 – 100 nanometers, where novel properties and functions occur because of the size.

NHLBI Career Transition Award (K22)

• Initiative Number: PAR-07-317
• Objective: Enable outstanding students with three to five years of postdoctoral training to obtain a research training experience in the NHLBI Division of Intramural Research and facilitate their successful transition to an extramural environment as independent researchers.

Occupational Safety and Health

• Initiative Number: PA-07-318
• Objective: Develop an understanding of the risks and conditions that are associated with occupational diseases and injuries, explore methods for reducing risks and for preventing or minimizing exposure to hazardous conditions in the workplace, and translate significant scientific findings into prevention practices and products that will effectively reduce work-related illnesses and injuries.

Organ Transplantation in Children: Clinical Trials

• Initiative Number: RFA-AI-07-006
• Objective: Improve graft acceptance and patient/graft survival in patients up to 20 years of age who have undergone heart, lung, liver, kidney or intestinal transplantation.

Software Development and Maintenance

• Initiative Number: PAR-07-235
• Objective: Improve, evaluate, and test existing informatics and computational biology software programs that originated in biomedical research laboratories in order to extend their applicability to the broader biomedical research community of translational and clinical researchers.

Stress Management Interventions to Reduce Risk of Coronary Artery Disease

• Initiative Number: PA-07-322
• Objective: Evaluate the effects of stress management interventions on intermediate outcomes purported to be in the biological or behavioral mechanistic pathway through which mental stress is thought to influence major adverse cardiac events in patients with confirmed coronary artery disease.

Need More Information?

We are always interested in receiving comments and suggestions from the community. If you or your organizations have questions for me or for the Institute, please contact me at nabele@nhlbi.nih.gov or Dr. Carl Roth at rothc@nhlbi.nih.gov.

For information on specific issues, the following contacts may be helpful:

For health related questions and publications, please contact the trained information specialists at the NHLBI Information Center (NHLBIinfo@nhlbi.nih.gov) or write to the Information Center at P.O. Box 30105, Bethesda, MD 20824-0105.

For communications pertaining to NHLBI policies and priorities, contact the NHLBI Office of Public Liaison, (nhlbi.listens@nih.gov).

For additional information regarding NHLBI events, consult the references provided or NHLBI Calendar. Most other NIH Institutes and Centers also maintain calendars on their Web sites. Links to their Web pages are at NIH Institutes, Centers, and Offices.

For Web related matters pertaining to the online version of the FYI from the NHLBI, contact the FYI from the NHLBI's Web Editor.